Work

Harnessing programmed death-ligand 1 as a prognostic marker in OSCC: Challenges and opportunities in the era of immunotherapy

Year: 2024

Type: article

Abstract: • Evaluating the role of PD-L1 as a prognostic marker in oral squamous cell carcinoma (OSCC). • Analyzing the challenges associated with PD-L1 assessment in the context of immunotherapy. • Exploring opportunities for leveraging PD-L1 to improve treatment outcomes in OSCC. • Discussing the evolving landscape of immunotherapy and its impact on PD-L1 as a biomarker in OSCC.

Source: Oral Oncology Reports

DOI: 10.1016/j.oor.2024.100641

Authors: Madhan Krishnan, Shyamaladevi Babu

Institution: Chettinad Academy of Research and Education

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,100